Biotechnology
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study. The drugmaker observed high rates of adverse side effects, which were mostly mild and gastrointestinal, among patients. A significant […]
Read More
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August 31, 2023. Victoria Klesty | Reuters Novo Nordisk on Thursday said it sued two compounding pharmacies in Florida for allegedly selling impure and “potentially unsafe” drugs claiming to contain semaglutide, the active ingredient in […]
Read More
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen jumped more than 80% on Thursday, putting it on track for its highest […]
Read More
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
A sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder | Reuters Three years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine. Only 15.7% of U.S. adults had received the newest Covid shots from Pfizer, Moderna and Novavax […]
Read More
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023. George Frey | Reuters The blockbuster diabetes drug Mounjaro is more effective for weight loss than another highly popular treatment, Ozempic, in overweight or […]
Read More
Oil and gas sector demands to allow go of carbon seize as alternative to local weather alter, IEA states
The Gorgon liquefied pure gas (LNG) and carbon capture and storage (CCS) facility, operated by Chevron Corp., on Barrow Island, Australia, on Monday, July 24, 2023. Bloomberg | Bloomberg | Getty Illustrations or photos The oil and gasoline industry requires to let go of the “illusion” that carbon capture engineering is a remedy to weather […]
Read More
U.S. to offer another round of free at-home Covid tests starting Monday
COVID-19 home test kits are pictured in a store window during the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., January 19, 2022. Carlo Allegri | Reuters The Biden administration on Monday said it is offering another round of free at-home Covid tests to U.S. households ahead of […]
Read More
U.S. crude oil fell into a bear current market this 7 days and could head reduce as China ‘haunts the market’
U.S. crude oil rates entered a bear market place this week, down 22% from September highs as traders wrangle around regardless of whether the spiral is pushed by market place fundamentals or just speculation. The West Texas Intermediate contrac t for December bought off speedily Thursday, dropping nearly 5% for the day to settle at […]
Read More
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022. Heiko Becker | Reuters The Centers for Disease Control and Prevention expedited the release of more than 77,000 additional doses of a new drug designed to protect infants from respiratory syncytial virus amid […]
Read More
Goldman thinks oil is headed increased yet again and endorses an selections trade to revenue from the rebound
The recent pullback in crude has manufactured phone solutions on U.S. oil an interesting hedge in opposition to continued geopolitical and inflation challenges that could thrust charges greater, in accordance to Goldman Sachs. Goldman’s commodity strategists expect West Texas Intermediate prices to rise to $88 per barrel in six months, 16% increased than current forward […]
Read More